Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction of Proteins Involved in Neuronal Proteinopathies. | Life (Basel) | 2023 | 37895336 | PubTator, text mining | PubMed |
| A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses. | Int J Mol Sci | 2023 | 37895145 | PubTator, text mining | PubMed |
| Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA. | Cancers (Basel) | 2023 | 37894350 | PubTator, text mining | PubMed |
| Afzelin induces immunogenic cell death against lung cancer by targeting NQO2. | BMC Complement Med Ther | 2023 | 37891619 | PubTator, text mining | PubMed |
| Sugarcane streak mosaic virus P1 protein inhibits unfolded protein response through direct suppression of bZIP60U splicing. | PLoS Pathog | 2023 | 37883577 | PubTator, text mining | PubMed |
| Decoding meningioma heterogeneity and neoplastic cell-macrophage interaction through single-cell transcriptome profiling across pathological grades. | J Transl Med | 2023 | 37880655 | PubTator, text mining | PubMed |
| IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma. | Nat Commun | 2023 | 37880243 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-sequencing reveals the poor prognostic value of ABCA1 in gastric adenocarcinoma. | Discov Oncol | 2023 | 37874419 | PubTator, text mining | PubMed |
| The intrinsically disordered region of eIF5B stimulates IRES usage and nucleates biological granule formation. | Cell Rep | 2023 | 37862172 | PubTator, text mining | PubMed |
| Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy. | Nat Commun | 2023 | 37848409 | PubTator, text mining | PubMed |
| A hybrid linear discriminant analysis and genetic algorithm to create a linear model of aging when performing motor tasks through inertial sensors positioned on the hand and forearm. | Biomed Eng Online | 2023 | 37845723 | PubTator, text mining | PubMed |
| A psychometric study of an executive function assessment instrument (TDI-FE). | BMC Psychol | 2023 | 37838747 | PubTator, text mining | PubMed |
| Coronaviruses spike glycoprotein endodomains: The sequence and structure-based comprehensive study. | Protein Sci | 2023 | 37833239 | PubTator, text mining | PubMed |
| Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma. | BMC Cancer | 2023 | 37828458 | PubTator, text mining | PubMed |
| Construction of 3D and 2D contrast-enhanced CT radiomics for prediction of CGB3 expression level and clinical prognosis in bladder cancer. | Heliyon | 2023 | 37809854 | PubTator, text mining | PubMed |
| Double-strand DNA break repair: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37808268 | PubTator, text mining | PubMed |
| Molecular basis of signal transduction mediated by the human GIPR splice variants. | Proc Natl Acad Sci U S A | 2023 | 37792509 | PubTator, text mining | PubMed |
| VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice. | PLoS Pathog | 2023 | 37788227 | PubTator, text mining | PubMed |
| Calreticulin Expression in Human Carcinomas: A Systematic Review and Meta-Analysis. | Asian Pac J Cancer Prev | 2023 | 37774043 | PubTator, text mining | PubMed |
| Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature. | Front Oncol | 2023 | 37771441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=18